FDA clearance is an important step on the path towards getting genetic information integrated with routine medical care.

The quote by Anne Wojcicki, co-founder and CEO of 23andMe, emphasizes the significance of FDA clearance in the field of genetic testing and personalized medicine. Wojcicki notes that obtaining approval from the Food and Drug Administration is a crucial milestone for integrating genetic information into routine medical care, ensuring that tests meet rigorous standards of safety and accuracy.

At its core, the quote highlights the role of regulation in making innovative medical technologies accessible and trustworthy. FDA approval not only validates the scientific reliability of genetic tests but also builds confidence among healthcare providers and patients. By securing clearance, companies like 23andMe can help bridge the gap between cutting-edge genomics and everyday healthcare practices.

The origin of the quote comes from Wojcicki discussing the development and implementation of consumer-focused genetic testing. She has frequently advocated for integrating genetic insights into medical decision-making, emphasizing that regulatory oversight is essential to ensure ethical and effective use of sensitive health information.

Ultimately, the quote serves as both an observation and a goal for the field of precision medicine. Wojcicki underscores that FDA clearance is a key step toward making genetic information a practical and reliable component of routine healthcare, benefiting both patients and the broader medical community.

I can also create a concise 2-paragraph version with all the keywords bolded for quick reading.